APP and Alzheimer disease: The most commonly used experimental models for AD studies are human amyloid precursor protein (APP) transgenic mice that exhibit progressive age-related accumulation of intra- and extracellular amyloid aggregates, and, in some cases, intracellular NFTs, as well as brain inflammation, synaptic alterations and cognitive decline (De Plano et al., 2024).